WuXi AppTec (OTCMKTS:WUXAY) Shares Down 4.9% – Here’s Why

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s share price fell 4.9% during trading on Tuesday . The company traded as low as $14.6816 and last traded at $14.7350. 1,463 shares traded hands during trading, a decline of 14% from the average session volume of 1,695 shares. The stock had previously closed at $15.50.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, WuXi AppTec presently has a consensus rating of “Moderate Buy”.

WuXi AppTec Stock Performance

The stock’s 50-day moving average price is $16.25 and its two-hundred day moving average price is $14.85.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings results on Monday, April 27th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.59 billion.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.